This trial is testing whether a daily injection of metreleptin is safe and effective for people with Partial Lipodystrophy.
2 Primary · 4 Secondary · Reporting Duration: 12 months
Active Control
Non-Treatment Group
65 Total Participants · 2 Treatment Groups
Primary Treatment: metreleptin · Has Placebo Group · Phase 3
Age Any Age · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: